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Dolly the sheep, the world's first mammal to be cloned from an adult cell was put to sleep last month. She was only six and a half years old -barely 40 in human terms. Already being treated for arthritis, Dolly was found to be suffering from a progressive lung disease.
The premature death of Dolly supports the view of some scientists in Japan and the US who maintain that all cloned animals are born with health problems. Harry Griffin, spokesperson for the Roslin Institute, near Edinburgh, where Dolly was created, was cautious on the significance of the ewe's death. 'Sheep can live to 11 or 12 years,' he said. 'Lung infections are common in older sheep, particularly those housed inside. A full postmortem is being conducted and we will report any significant findings.' After the postmortem examination, Dolly will be stuffed and put on display at the National Museum of Scotland.
Dolly was born on July 5 1996, from three mothers: one ewe to provide the DNA, another to provide the egg into which the DNA was injected, and a third to carry the resulting cloned embryo to term. Dolly's genetic mother (the DNA was taken from an udder cell) was six when she was cloned. This may mean that the real age of clones is their age since birth, plus the age of the genetic donor.
The It is clear then that, while stem cell research is still at an early stage of development and there are many uncertainties, enough is known already to suggest that the medical benefits of a better understanding of stem-cell biology might be considerable. But it cannot be advanced without a source of human embryos.
While it has been suggested that a better understanding of the properties of embryonic stem cells could be achieved by work in the mouse and other animals, it is already clear that there are many differences between species in the properties of these cells.
"It is not surprising that this field has caused and still causes considerable controversy. It is particularly unfortunate that the term 'therapeutic cloning' has been applied in an uncritical and blanket fashion. It is difficult to dissociate it in people's minds from reproductive cloning, the objective of which is totally different," says David Weatherall, former head of the Institute of Molecular Medicine, at Oxford University.
Many countries are finding it difficult to sort out these ethical issues and to define a code of practice for work in the stem cell field. In the UK, after an extensive study followed by a report from the chief medical officer's expert group, and wide debate in parliament, it is permissible to use human embryonic stem cells derived from 'leftover' embryos not required by the genetic parents for reproduction, or from embryos created for research purposes by in vitro fertilization, or the nuclear transfer technique, for specifically defined areas of research. The legality of this position is still questioned by those who oppose any form of research on embryos.
In Germany, research on human embryonic stem cells was prohibited, although it is allowed in exceptional cases, provided it is carried out on imported stem cells derived before January 2000 from surplus embryos.
In the US, President Bush announced in August 2001 that federal funding for research in this field could be used only for work on 60 stem-cell lines that had been derived from excess human embryos before his announcement. There is, however, no federal law or policy prohibiting the private sector from creating stem cells by in vitro fertilization or nuclear transfer.
Some of these issues are described in a recent account of stem cell research, based on the assessment and work of a committee chaired by cancer researcher Bert Vogelstein, under the auspices of the US National Research Council. "The NRC report reminds us how difficult it is to develop an ethical framework for a research field that is so full of uncertainties and potentials, and one in which the technology skates close to activities that are repugnant to many people. But one thing this increasingly bitter debate has already made clear is that scientists must be much more precise, and less emotive, in the language they use to describe what they do," says Weatherall.
